← All trials
NCT07144111
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 21, 2025
- Primary completion
- Sep 6, 2026
- Completion date
- Sep 6, 2026
- First posted
- Aug 27, 2025
- Last posted
- Nov 14, 2025
- Enrollment
- 32
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.